期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
A meta-analysis of soluble suppression of tumorigenicity 2 (sST2) and clinical outcomes in pulmonary hypertension 被引量:5
1
作者 king sum luk Christina Ip +10 位作者 Meng-Qi GONG Sunny Hei WONG William KK Wu Mei DONG Guang-Ping LI Ka Pang Chan Yi-Mei DU Tong LIU Martin CS Wong David Shu Cheong Hui Gary Tse 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2017年第12期766-771,共6页
Suppression of Tumorigenicity 2 (ST2) is a member of the interleukin (IL)-1 receptor family The ST2 receptor exists in two isoforms - ST2 ligand (ST2L) and soluble ST2 (sST2).ST2L is a membrane receptor and sS... Suppression of Tumorigenicity 2 (ST2) is a member of the interleukin (IL)-1 receptor family The ST2 receptor exists in two isoforms - ST2 ligand (ST2L) and soluble ST2 (sST2).ST2L is a membrane receptor and sST2 is a trun- cated receptor which is soluble in the blood, allowing it to be detected in serum. IL-33 is a member of the IL-1 family of ligand and is the fimctional ligand of ST2L receptor. It binds to the ST2L, thereby mediating its immune function. 展开更多
关键词 MORTALITY Poor outcomes Pulmonary hypertension Soluble suppression of tumorigenicity 2 SST2
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部